ARCHIVES

NCI advisors approve recompetition of $62 million phase II contracts program.

This article is from The Cancer Letter archive.

Vol. 30 No. 44 | November 19, 2004

Download PDF Visit The Full Archive

Related Articles

GA101 Associated with Better PFS In Phase III Trial Versus Rituximab in CLL

July 26, 2013

Cancer Genetics: risk from Three BRCA Mutations Lower Than Expected, NCI Finds

May 23, 1997

Nutrition Research Tests Hypotheses, Seeks Explanation Of Differences

August 14, 1981

Dalton To Head Moffitt Cancer Center; HHS Appoints Gerberding CDC Director

July 12, 2002

Breast Cancer Vs. Other Cancers In Budget Showdown

July 3, 1992

Research Regulation: NRC fines NIH for Not Securing Radioactive Materials

September 13, 1996